BeiGene
US Headquarters
BeiGene, a global biotechnology company focused on developing and commercializing innovative cancer medicines worldwide purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, NJ to build a new state-of-the-art manufacturing campus and clinical research & development center.
Project Details:
Meyer, in conjunction with lead architect IPS, is part of the team designing approximately 400,000 square feet of dedicated commercial-stage biologic pharmaceutical manufacturing, clinical R&D space, and office space. Construction of the initial phase is expected to commence in 2022 and be completed in late 2023 or in 2024.
Guiding Principles
Security
Integrated Technology
Universal Design
Human Centric User Experience
Adaptability & Flexibility
